Literature DB >> 30819345

Intrauterine Growth Restriction: Postnatal Monitoring and Outcomes.

Kalpashri Kesavan1, Sherin U Devaskar2.   

Abstract

Intrauterine growth restriction (IUGR) is an important cause of fetal, perinatal and neonatal morbidity and mortality. IUGR occurs because of multiple reasons. Neonates with IUGR experience acute problems in the perinatal and early neonatal period that can be life-threatening. The unfavorable uterine environment causing growth restriction results in programming that predisposes IUGR infants to long-term health issues such as poor physical growth, metabolic syndrome, cardiovascular disease, neurodevelopmental impairment and endocrine abnormalities, warranting careful monitoring. It is imperative to strike the balance between achieving optimal catch-up to promote normal development, while preventing the onset of cardiovascular and metabolic disorders in the long-term.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fetal programming; Growth hormone; Intrauterine growth restriction (IUGR); Metabolic programming; Small for gestational age (SGA)

Mesh:

Year:  2019        PMID: 30819345     DOI: 10.1016/j.pcl.2018.12.009

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  23 in total

Review 1.  Tracking placental development in health and disease.

Authors:  John D Aplin; Jenny E Myers; Kate Timms; Melissa Westwood
Journal:  Nat Rev Endocrinol       Date:  2020-06-29       Impact factor: 43.330

2.  Prenatal metal(loid) mixtures and birth weight for gestational age: A pooled analysis of three cohorts participating in the ECHO program.

Authors:  Caitlin G Howe; Sara S Nozadi; Erika Garcia; Thomas G O'Connor; Anne P Starling; Shohreh F Farzan; Brian P Jackson; Juliette C Madan; Akram N Alshawabkeh; José F Cordero; Theresa M Bastain; John D Meeker; Carrie V Breton; Margaret R Karagas
Journal:  Environ Int       Date:  2022-01-23       Impact factor: 9.621

3.  Tolerable upper intake level for dietary sugars.

Authors:  Dominique Turck; Torsten Bohn; Jacqueline Castenmiller; Stefaan de Henauw; Karen Ildico Hirsch-Ernst; Helle Katrine Knutsen; Alexander Maciuk; Inge Mangelsdorf; Harry J McArdle; Androniki Naska; Carmen Peláez; Kristina Pentieva; Alfonso Siani; Frank Thies; Sophia Tsabouri; Roger Adan; Pauline Emmett; Carlo Galli; Mathilde Kersting; Paula Moynihan; Luc Tappy; Laura Ciccolallo; Agnès de Sesmaisons-Lecarré; Lucia Fabiani; Zsuzsanna Horvath; Laura Martino; Irene Muñoz Guajardo; Silvia Valtueña Martínez; Marco Vinceti
Journal:  EFSA J       Date:  2022-02-28

4.  Impact of Metformin Treatment on Human Placental Energy Production and Oxidative Stress.

Authors:  Jane L Tarry-Adkins; India G Robinson; Rebecca M Reynolds; Irving L M H Aye; D Stephen Charnock-Jones; Benjamin Jenkins; Albert Koulmann; Susan E Ozanne; Catherine E Aiken
Journal:  Front Cell Dev Biol       Date:  2022-06-17

5.  A Metabolomic Profiling of Intra-Uterine Growth Restriction in Placenta and Cord Blood Points to an Impairment of Lipid and Energetic Metabolism.

Authors:  Juan Manuel Chao de la Barca; Floris Chabrun; Tiphaine Lefebvre; Ombeline Roche; Noémie Huetz; Odile Blanchet; Guillaume Legendre; Gilles Simard; Pascal Reynier; Géraldine Gascoin
Journal:  Biomedicines       Date:  2022-06-15

6.  Randomized Controlled Trial Examining the Efficacy of Adding Financial Incentives to Best practices for Smoking Cessation Among pregnant and Newly postpartum Women.

Authors:  Stephen T Higgins; Tyler D Nighbor; Allison N Kurti; Sarah H Heil; Eric P Slade; Donald S Shepard; Laura J Solomon; Mary Ellen Lynch; Harley K Johnson; Catherine Markesich; Peter L Rippberger; Joan M Skelly; Michael DeSarno; Janice Bunn; Jessie B Hammond; Maria L Roemhildt; Rhonda K Williams; Deirdre M O'Reilly; Ira M Bernstein
Journal:  Prev Med       Date:  2022-03-03       Impact factor: 4.637

7.  Plasma Adipokines Profile in Prepubertal Children with a History of Prematurity or Extrauterine Growth Restriction.

Authors:  María Dolores Ordóñez-Díaz; Mercedes Gil-Campos; Katherine Flores-Rojas; María Carmen Muñoz-Villanueva; Concepción María Aguilera-García; María Jose de la Torre-Aguilar; Juan Luis Pérez-Navero
Journal:  Nutrients       Date:  2020-04-24       Impact factor: 5.717

8.  Effectiveness of routine third trimester ultrasonography to reduce adverse perinatal outcomes in low risk pregnancy (the IRIS study): nationwide, pragmatic, multicentre, stepped wedge cluster randomised trial.

Authors:  Jens Henrichs; Viki Verfaille; Petra Jellema; Laura Viester; Eva Pajkrt; Janneke Wilschut; Henriëtte E van der Horst; Arie Franx; Ank de Jonge
Journal:  BMJ       Date:  2019-10-15

9.  Liver transcriptome profiling and functional analysis of intrauterine growth restriction (IUGR) piglets reveals a genetic correction and sexual-dimorphic gene expression during postnatal development.

Authors:  Hongmei Gao; Longchao Zhang; Ligang Wang; Xin Liu; Xinhua Hou; Fuping Zhao; Hua Yan; Lixian Wang
Journal:  BMC Genomics       Date:  2020-10-08       Impact factor: 3.969

10.  Overexpression of microRNAs miR-25-3p, miR-185-5p and miR-132-3p in Late Onset Fetal Growth Restriction, Validation of Results and Study of the Biochemical Pathways Involved.

Authors:  Gabriela Loscalzo; Julia Scheel; José Santiago Ibañez-Cabellos; Eva García-Lopez; Shailendra Gupta; José Luis García-Gimenez; Salvador Mena-Mollá; Alfredo Perales-Marín; José Morales-Roselló
Journal:  Int J Mol Sci       Date:  2021-12-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.